A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience-Reference-Cited by-同舟云学术

A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience

Published:2020-06 Issue: Volume:33 Page:118-125
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Lowder Cinthya Y.,Dhir Teena,Goetz Austin B.,Thomsett Henry L.,Bender Joseph,Tatarian Talar,Madhavan Subha,Petricoin Emanuel F.,Blais Edik,Lavu Harish,Winter Jordan M.,Posey James,Brody Jonathan R.,Pishvaian Michael J.,Yeo Charles J.

Funder

Concetta Greenberg Fund

PanCAN-AACR Research Acceleration Network

Thomas Jefferson University

NIH/NIGMS

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference49 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2017

2. Perioperative and survival outcomes following neoadjuvant FOLFIRINOX versus gemcitabine abraxane in patients with pancreatic adenocarcinoma;Chapman;JOP,2018

3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011

5. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N. Engl. J. Med.,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential;Journal of Experimental & Clinical Cancer Research;2023-10-26

2. Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies;Cancer Treatment Reviews;2021-12

3. Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies;JCO Precision Oncology;2021-08

4. The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic;Annals of Surgery;2021-07-02